<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="308127">
  <stage>Registered</stage>
  <submitdate>28/06/2009</submitdate>
  <approvaldate>13/08/2009</approvaldate>
  <actrnumber>ACTRN12609000701224</actrnumber>
  <trial_identification>
    <studytitle>Laser therapy versus local steroid injection for carpal tunnel syndrome</studytitle>
    <scientifictitle>A randomised controlled trial of the effect of low level laser therapy versus local steriod injection on nerve conduction in those with carpal tunnel syndrome</scientifictitle>
    <utrn />
    <trialacronym />
  </trial_identification>
  <conditions>
    <healthcondition>carpal tunnel syndrome</healthcondition>
    <conditioncode>
      <conditioncode1>Neurological</conditioncode1>
      <conditioncode2>Other neurological disorders</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Neurological</conditioncode1>
      <conditioncode2>Dementias</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>laser therapy was administered by applying a Infrared laser diode in characteristics of 775 nm amplitude, 6500 Hz frequency and an intensity of 20  at five points over 11 seconds along the median nerve passage above the carpal tunnel. A total of 10 laser therapies were performed every other day for 3 week. In Steroid injection group   50mg Hydrocortisone (2 ml) was injected into the carpal tunnel only once. The wrist was positioned on a hard surface in slight dorsiflexion and the needle was advanced at 30-degree angle to the skin, medial to the palmaris longus.</interventions>
    <comparator>This study assess low level laser versus steroid injection for carpal tunnel syndrome</comparator>
    <control>Active</control>
    <interventioncode>Treatment: Other</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>nerve conduction study was assessed by electrodiagnostic study.</outcome>
      <timepoint>at baseline and 8 weeks after treatment</timepoint>
    </primaryOutcome>
    <primaryOutcome>
      <outcome>nerve conduction study</outcome>
      <timepoint>at baseline and 8 weeks after treatment</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Nil</outcome>
      <timepoint>Nil</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>mild to moderate carpal tunnel syndrome without previous treatment</inclusivecriteria>
    <inclusiveminage>0</inclusiveminage>
    <inclusiveminagetype>No limit</inclusiveminagetype>
    <inclusivemaxage>0</inclusivemaxage>
    <inclusivemaxagetype>No limit</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>severe carpal tunnel syndrome,previous treatment</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment />
    <sequence />
    <masking />
    <assignment />
    <designfeatures />
    <endpoint />
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase />
    <anticipatedstartdate>5/01/2009</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>38</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Completed</recruitmentstatus>
    <recruitmentcountry />
    <recruitmentstate />
    <countryoutsideaustralia>
      <country>Iran, Islamic Republic Of</country>
      <state />
    </countryoutsideaustralia>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Hospital</primarysponsortype>
    <primarysponsorname>501 army hospital</primarysponsorname>
    <primarysponsoraddress>western Fatemi street, Tehran,Iran
postcode:123215433</primarysponsoraddress>
    <primarysponsorcountry>Iran, Islamic Republic Of</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Hospital</fundingtype>
      <fundingname>501 army hospital</fundingname>
      <fundingaddress>western Fatemi street,Tehran,Iran
postcode:123215433</fundingaddress>
      <fundingcountry>Iran, Islamic Republic Of</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname />
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>The aim of this study is comparing two conservative treatment methods for Carpal tunnel syndrome.A new conservative treatment is laser.</summary>
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>mahsa asheghan</name>
      <address>University of social welfare and rehabilitation,Evin street, Tehran,Iran.
postcode:1316785754</address>
      <phone>+982188058837</phone>
      <fax />
      <email>fsafar@razi.tums.ac.ir</email>
      <country>Iran, Islamic Republic Of</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name>mahsa asheghan</name>
      <address>36 no, Zartoshtian street,Tehran,Iran.
postcode:1436913511</address>
      <phone>+982188058837</phone>
      <fax />
      <email>fsafar@razi.tums.ac.ir</email>
      <country>Iran, Islamic Republic Of</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Updating Information</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>